Detecting early immunogenicity with HypoSkin®
Explore a translational, animal-free model for evaluating unwanted immune responses to injectable therapeutics
HypoSkin® – A structurally stable, injectable, & immunocompetent human skin model to assess immunogenicity of therapeutic compounds
Get your copy of the white paper and discover how HypoSkin® enables profiling of unwanted immune response in an injectable, structurally stable human skin model. Learn how pharma and biotech teams are using this ex vivo platform to evaluate the early stages of immunogenicity of biologics and vaccines with high cellular resolution.
Please fill in the form below to access the white paper.
Comments are closed.
